Clinical Certificate

Drug Treatments in Affective Disorders

Date: September 2020
Venue: The International Centre For Life (Conferences), Times Square, Newcastle Upon Tyne, NE1 4EP
Accommodation: Jury's Inn, Scotswood Road, Newcastle , NE1 4AD
(accommodation is bookable separately when you complete the online booking form)

Programme

Programme to be confirmed

Last edited 11th June 2019

Learning Objectives

  • Natural history and pathophysiology of affective disorders
    • To understand the Natural History of Mood Disorders
    • To be aware of the main theories of the pathophysiology of mood disorders and the
      relationship of these to drugs
  • Pharmacokinetics and mechanism of action of antidepressants
    • To understand the basic pharmacokinetics of antidepressants
    • To understand the relevance of differing pharmacokinetic properties of antidepressants to their clinical usage
    • To understand the presumed mechanism of action of various classes of antidepressant drugs
  • Antidepressants in clinical practice
    • To recognise various stages in the management of patients with antidepressants
    • To understand how various classes of antidepressants may be used clinically
    • To know the details of published guidelines regarding the choice and clinical usage of antidepressants
  • Management of treatment resistant depression
    • To understand the epidemiology, clinical features and associations of this disorder.
    • To be able to construct a rational management plan.
    • To explore the evidence base in this topic and make rational pharmacological treatment plans.
    • To be able to consider what additional investigations or treatments are required.
  • Lithium
    • To understand how Lithium may be used clinically
    • To know the details of published guidelines regarding the choice and clinical usage of Lithium
    • To appreciate the neurobiological underpinnings of Lithium’s actions
  • Other treatments for bipolar disorder
    • To be able to construct a rational management plan.
    • To explore the evidence base in this topic and make rational pharmacological treatment plans.
    • To be able to consider what additional investigations or treatments are required.

This module is eligible for 10 CPD hours which are subject to peer group review.

For further details contact , BAP Executive Officer

Feedback from 2018 Module

"Excellent. I will highly recommend this module to my colleagues and trainees, thank you"

"Very informative, excellent educational lectures and very well organised, thanks!"

"Excellent – this is the best BAP module I have attended"

"Excellent sessions and excellent speakers!"